The largest database of trusted experimental protocols

Rhbmp 7

Manufactured by ProSpec
Sourced in Israel

RhBMP-7 is a recombinant human bone morphogenetic protein-7 (rhBMP-7) laboratory reagent. It is a member of the transforming growth factor-beta (TGF-β) superfamily and plays a role in bone and cartilage formation.

Automatically generated - may contain errors

2 protocols using rhbmp 7

1

Optimization of rhBMP-7 Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prior to the in vivo studies, the biological activity of rhBMP-7 from different manufacturers was determined in an alkaline phosphatase (ALP) activity assay in ATDC5 cells, amongst them rhBMP-7 from R&D and ProSpec-Tany. rhBMP-7 from ProSpec-Tany showed the highest biological activity, as shown in Additional file 2, and was further chosen to be employed in the in vivo studies.
rhBMP-7 (CYT-276, ProSpec-Tany TechnoGene Ltd) was reconstituted in 60 μl sterile water. This solution was dialyzed against a buffer solution containing 17% sucrose, 20% mannitol, 332 mM glycine, and 0.8% Tween 20, using a slide-A-Lyzer dialysis cassette (66454, Thermo Fisher Scientific Inc., Rockford, IL, USA) with a molecular weight cutoff of 10 kDa overnight with 4 buffer changes. The final solution containing 300 μg of rhBMP-7 (calculated amount) was freeze-dried overnight and reconstituted in sterile water, to achieve a final concentration of 250 μg rhBMP-7 in 40 μl buffer solution containing 1% sucrose, 1.2% mannitol, 20 mM glycine, and 0.05% Tween 20. Activity of the dialysate was shown to be retained in vitro through its capacity to induce ALP production in mice ATDC5 cells. Additional file 2 shows the biologic activity of the dialyzed rhBMP-7 compared with the pre-dialyzed rhBMP-7.
+ Open protocol
+ Expand
2

Fibroblast Phenotypic Modulation by TGF-β and BMP-7

Check if the same lab product or an alternative is used in the 5 most similar protocols
Myocardial fibroblasts were divided into 5 groups: the control group (normal cells); the TGF-β group (cells treated with 10−6 mol/L TGF-b for 48 h); the Smad3 siRNA group (cells treated with 10−6 mol/L TGF-β for 48 h and then transfected with Smad3 siRNA); the BMP-7 group (cells treated with 10−6 mol/L TGF-β for 48 h and then cultured with 0.5 μg/mL recombinant human BMP-7 (rhBMP-7, Prospec, Israel); and the Smad1/5 siRNA group (cells treated with both TGF-β and rhBMP-7 and then transfected with Smad1/5 siRNA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!